Your session is about to expire
← Back to Search
CBL-514 for Reducing Abdominal Fat
Study Summary
This trial tests a drug to reduce fat under the skin, to see if it's safe, effective and tolerated.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am not pregnant or breastfeeding and agree to use birth control during the study and for 90 days after.I have or had a hernia near my belly button.My diabetes is not well-controlled, with recent or expected medication changes.I have liver cirrhosis with liver tests more than three times the normal limit.I have no allergies to the study drug or its components, except for food allergies.I have a blood clotting disorder or I'm on blood thinners.I haven't had cancer, except for certain skin cancers, in the last 5 years.I have visible folds of fat or skin on my abdomen when standing.I am a male and agree to use a condom and not donate sperm from the start of the treatment until 90 days after it ends.I haven't used any experimental drugs or devices in the last 3 months.I have kidney problems.I have not used any medication injected under the skin in the treatment area within the last 4 weeks.I am on long-term steroids or immunosuppressants, not including asthma inhalers or topical creams for skin issues.I am between 18 and 64 years old.My doctor has rated my abdominal fat as moderate or severe.My weight has been stable, with less than a 3 kg change, for the last 3 months.I am not on medication that affects CYP1A2 enzymes or could risk my safety in the study.I haven't used weight loss drugs or GLP-1 agonists in the last 6 months.I have undergone specific medical procedures.I have signed the consent form and can follow the study's procedures.
- Group 1: CBL-514 Injection
- Group 2: 0.9% Sodium Chloride
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is eligibility for this trial restricted to individuals of a certain age?
"This trial is only open to individuals who have attained the age of majority and are under 64 years old."
Who meets the eligibility criteria for involvement in this research?
"This clinical trial seeks 100 individuals with subcutaneous fat, aged between 18 and 64. To be eligible for the study, patients must meet all of the following criteria: they must identify as male or female; have a BMI ranging from 18.5 to 32kg/m2 and body weight greater than 50 kg at Screening and Day 1; possess abdominal fat graded by an Investigator as Grade 3 (moderate) or 4 (severe); maintain stable bodyweight within 3 kilograms per participant report over three months before screening until end of the study; sustain a consistent lifestyle in terms of exercise, dietary habits and smoking behaviour throughout that period; understand"
What health risks does CBL-514 Injection pose for people undergoing treatment?
"Given that CBL-514 Injection is in its second clinical trial phase, supporting data on safety exists, but efficacy remains unknown. Thus, we estimate the treatment's security with a score of 2."
What is the current recruitment number for this experiment?
"Affirmative. Accessible on the clinicaltrials.gov website is evidence that this research study, which was initially listed in May 30th 2023, is actively recruiting patients. At present, 100 individuals are required to be enlisted from a single location."
Are new participants able to join this clinical trial?
"Affirmative. According to the information published by clinicaltrials.gov, this research study is open for recruitments. It was originally posted on May 30th 2023 and last updated June 5th 2023 with a need of 100 participants from 1 medical site."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger